Bristol Myers Squibb Commits to Veeva Vault CRM

For next-generation CRM with deep, industry-specific AI agents

Veeva Systems announced that Bristol Myers Squibb (BMS) has committed to Veeva Vault CRM.

“Technology is fundamentally reshaping the way we engage with our customers and the patients they serve,” said Greg Meyers, executive vice president, chief digital and technology officer at Bristol Myers Squibb. “We are excited to take the next step in our long-standing relationship with Veeva by using Vault CRM to help transform how healthcare practitioners make informed decisions about the increasingly complex array of innovative medicines available today.”

Marketing Technology News: MarTech Interview with Lee McCance, Chief Product Officer @ Adverity

“By embedding AI into every step of the customer journey — from how practitioners receive valuable information about our portfolio to how they engage with our field force — Veeva is ideally positioned to support us in our mission to deliver life-changing medicines to patients worldwide,” added Meyers.

“We appreciate the trust and partnership and are committed to supporting Bristol Myers Squibb in their mission to provide medicines that transform the lives of patients with serious diseases,” said Veeva CEO Peter Gassner. “With Vault CRM we are delivering the next generation of CRM with embedded AI agents to advance healthcare practitioner engagement and help get the right treatments to patients faster.”

Marketing Technology News: What is a Full Stack Marketer; What MarTech Matters Most to Full Stack Marketers?

Vault CRM is part of the Vault CRM Suite of applications that provide the technology foundation for commercial execution. The first Veeva AI agents for Vault CRM — Pre-call Agent, Content Agent, Free Text Agent, and Voice Agent — are planned for availability in December 2025.